These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28413097)

  • 21. Metabotropic glutamate receptors in the control of mood disorders.
    Witkin JM; Marek GJ; Johnson BG; Schoepp DD
    CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):87-100. PubMed ID: 17430147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamate-Based Drug Discovery for Novel Antidepressants.
    Pałucha-Poniewiera A; Pilc A
    Expert Opin Drug Discov; 2016 Sep; 11(9):873-83. PubMed ID: 27409299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
    Koike H; Iijima M; Chaki S
    Neuropharmacology; 2011 Dec; 61(8):1419-23. PubMed ID: 21903115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of mGlu
    Pałucha-Poniewiera A
    Pharmacol Biochem Behav; 2022 Oct; 220():173454. PubMed ID: 36038006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
    Palucha A; Pilc A
    Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamate-based antidepressants: preclinical psychopharmacology.
    Pilc A; Wierońska JM; Skolnick P
    Biol Psychiatry; 2013 Jun; 73(12):1125-32. PubMed ID: 23453290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.
    Pałucha A; Pilc A
    Pol J Pharmacol; 2002; 54(6):581-6. PubMed ID: 12866712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants.
    Chaki S; Fukumoto K
    Pharmaceuticals (Basel); 2015 Sep; 8(3):590-606. PubMed ID: 26393618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.
    Chruścicka-Smaga B; Machaczka A; Szewczyk B; Pilc A
    Pharmacol Rep; 2023 Dec; 75(6):1341-1349. PubMed ID: 37932583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Koike H; Fukumoto K; Iijima M; Chaki S
    Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid-Acting Antidepressants.
    Witkin JM; Knutson DE; Rodriguez GJ; Shi S
    Curr Pharm Des; 2018; 24(22):2556-2563. PubMed ID: 30058481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of early-life stress, on group III mGlu receptor levels in the rat hippocampus: effects of ketamine, electroconvulsive shock therapy and fluoxetine treatment.
    O' Connor RM; Pusceddu MM; Dinan TG; Cryan JF
    Neuropharmacology; 2013 Mar; 66():236-41. PubMed ID: 22609536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.
    Pilc A; Machaczka A; Kawalec P; Smith JL; Witkin JM
    Expert Opin Drug Discov; 2022 Oct; 17(10):1131-1146. PubMed ID: 35934973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mGlu2/3 agonist-induced hyperthermia: an in vivo assay for detection of mGlu2/3 receptor antagonism and its relation to antidepressant-like efficacy in mice.
    Gleason SD; Li X; Smith IA; Ephlin JD; Wang XS; Heinz BA; Carter JH; Baez M; Yu J; Bender DM; Witkin JM
    CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):554-66. PubMed ID: 23574174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice.
    Ago Y; Yano K; Araki R; Hiramatsu N; Kita Y; Kawasaki T; Onoe H; Chaki S; Nakazato A; Hashimoto H; Baba A; Takuma K; Matsuda T
    Neuropharmacology; 2013 Feb; 65():29-38. PubMed ID: 23022081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting of metabotropic glutamate receptors for the treatment of schizophrenia.
    Chaki S; Hikichi H
    Curr Pharm Des; 2011; 17(2):94-102. PubMed ID: 21355835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.
    Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM
    Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are compounds acting at metabotropic glutamate receptors the answer to treating depression?
    Palucha A
    Expert Opin Investig Drugs; 2006 Dec; 15(12):1545-53. PubMed ID: 17107280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid-acting antidepressants.
    Witkin JM; Martin AE; Golani LK; Xu NZ; Smith JL
    Adv Pharmacol; 2019; 86():47-96. PubMed ID: 31378256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression.
    Wang YT; Wang XL; Feng ST; Chen NH; Wang ZZ; Zhang Y
    Pharmacol Res; 2021 Sep; 171():105761. PubMed ID: 34242798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.